Inicio Blog Página 36

Latest issue of the eJIFCC 2016 Vol 27 no. 3

0

eJIFCC 2016 Vol 27 no° 3

  1. Foreword of the editor. Gábor L. Kovács
  2. The world is changing: are we ready?. Alan S. Jaffe
  3. Analytical issues with natriuretic peptides – has this been overly simplified?. Alexander G. Semenov, Alexey G. Katrukha
  4. Can natriuretic peptides be used to guide therapy? Antoni Bayes-Genis, Josep Lupón, Allan S. Jaffe
  5. High sensitivity cardiac troponin assays – How to implement them successfully. Frederick K. Korley. , Allan S. Jaffe
  6. Soluble ST2 and galectin-3 – what we know and don’t know analytically. Thomas Mueller, Benjamin Dieplinger
  7. ST2 and Galectin-3 – Ready for prime time? Wouter C. Meijers, A. Rogier van der Velde, Rudolf A. de Boer
  8. Emerging and disruptive technologies. Larry J Kricka

Click here to download a PDF of the full issue.

Listado de emisiones anteriores

No se encontraron entradas.

#2016AACC AACC Mobile App

0

The AACC Annual Scientific Meeting & Clinical Lab Expo mobile app is the official 2016 AACC Annual Scientific Meeting virtual planner. This powerful platform allows you to build your meeting itinerary, search for sessions and speakers, find exhibitors by product and/or keywords, and locate auxiliary meetings and industry workshops. You can even use the app to add personal meetings to your schedule.

International Cancer Research & Oncology 2016 Virtual Event

0

The 4th Annual Cancer Research & Oncology Virtual Conference, taking place October 5-6, 2016 at no cost to attendees. This premier cancer research conference makes it easier and more cost-effective for the cancer research community to come together online to learn about recent advances in cancer research. The conference has proven to be a great success in disseminating knowledge and encouraging collaboration and connections between colleagues.

Visit the Event Overview to learn more about the topics covered.

Poster Submission Guidelines

Submission is free. Please see the Submission Guidelines and learn more about participating in a virtual poster session. This virtual poster session allows previously presented posters from within the last year in addition to new and original data. Posters will be published and live during the conference October 5-6, 2016, and will remain accessible in the virtual environment during the on demand period. Learn More

Deadline: The deadline for electronic submission is 5:00pm PT, Friday, September 16, 2016.

Topics for this year’s conference include

  • Innovations in Cancer Immunotherapy
  • Targeted, Precision Cancer Therapies for Advanced Disease
  • Detection of Rare Cancer Mutations and Implications for Treatment
  • Novel Systems to Monitor Disease and Better Predict Clinical Outcomes for Cancer Patients
  • Mini-Symposiums on Prostate cancer, Breast cancer, Brain cancer, and the kRAS initiative

No more information is available on infobioquimica.org. For further requests, you can contact the organizers of the event.

Structure of rhinovirus C revealed

0

Rhinovirus C, along with rhinoviruses A and B, is a leading cause of common colds. These viruses can also cause severe respiratory infections in infants and young children, and cause serious illness for those with asthma and other chronic respiratory conditions.

Scientists have tried unsuccessfully for years to develop treatments for rhinoviruses. Viruses work by binding to and infecting cells and then using the host cell’s machinery to make more viruses (replicate) and become infectious. Thus it’s important to identify the receptors on human cells that these viruses bind.

A team led by Dr. Ann Palmenberg at the University of Wisconsin–Madison and Dr. Michael Rossmann at Purdue University has been working to understand the structure of rhinovirus C, which is a type of enterovirus. Such studies have been hampered by the difficulty of growing the viruses in the laboratory.

The researchers previously found that rhinovirus C infects cells via a specific surface receptor called cadherin-related protein 3 (CDHR3). In order to grow enough virus for structural analysis, the group engineered cells to have CDHR3. They then infected the cells with a type of rhinovirus C that was adapted for tissue culture. The research was supported by NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Results appeared online in Proceedings of the National Academy of Sciences on July 13, 2016.

Using the imaging technique of cryo-electron microscopy, the team examined the structure of the viral particles and observed 2 forms. Full particles contained key proteins and were infectious. Empty particles (about 30% of all particles) didn’t contain genetic material and weren’t able to infect cells.

The empty particles may simply be byproducts of how the virus is assembled. Alternatively, the researchers suggest, the empty particles could be immune decoys. “No other rhinoviruses seem to do this naturally,” Palmenberg says.

The group created 3-D structures of the full and empty particles at resolutions of 2.8 Å and 3.2 Å, respectively. They found that the outer surface of the full viral particle has 60 spike-like protrusions, or “fingers.” Other enteroviruses have smoother, spherical surfaces. These fingers might play a role in triggering immune responses. Empty particles contain fingers as well. Next to each finger is a depression, which may be where the virus surface binds with the host cell. These findings offer insights for the development of vaccines or drugs to prevent or treat infections.

The scientists also found that rhinovirus C has pocket-like structures that, unlike other enteroviruses, are collapsed and partially filled. This may explain why rhinovirus C is resistant to anti-viral drugs designed to fit in the pocket.

“Rhinovirus C has been the ‘missing link’ in explaining illness caused by the common cold,” Rossmann says. “This is sure to spark major new efforts toward the development of vaccines and antiviral drugs, particularly for the prevention of asthma.”

Author: Carol Torgan, Ph.D.

Source: NIH

Invitation to collaborative translation project

0

What is IFCC eAcademy?

The IFCC eAcademy is an open educational resource containing distance-learning materials created and/or reviewed by IFCC experts for the continuous professional training development of members of IFCC member organizations.

These educational materials are composed of about 45 videos counting more than 25 hours. Up to now, this huge amount of knowledge in laboratory sciences is available only in English.

To facilitate access to this knowledge to a greater number of professionals, IFCC has
initiated a project of collaborative translation of these videos to Spanish.

What does collaborative translation mean?

It means that a large number of people work simultaneously in the translation of videos from English to Spanish. Each of those people are called “collaborators”. Therefore, a small contribution in translating the video coupled with the contributions of other partners can achieve the enormous task of translating all the educational content. Everything
counts; even the translation of a single word is helpful if we add the efforts of many.

How I can help?

To coordinate collaborative work IFCC uses a platform called Amara. If you speak English and Spanish (whatever is your mother or second language) you can help. All contributions are important. There are no small tasks in a collaborative project. Just go online: http://amara.org/es/teams/ifcc/

Then go to link “Register” to create an account on the website. You can also log in using any of your Google, Facebook or LinkedIn accounts. Once you are registered, you can ask the administrator to be add to the translation team as a “collaborator”.

Those who only speaks English can help making the video transcript. They can transform in text the words spoken in English at the video. This transcript facilitates the subsequent task of translators.

If you speak English and Spanish and are expert in any of the topics of the videos, you can offer your work as a “reviewer”. A reviewer is somebody who speak both languages fluently and at the same time have knowledge about the video content. He or She may approve translations suggested by translators. If you want to become a reviewer, just contact IFCC or contact the administrator of the platform.

Can anyone participate?

Anyone who speaks English and Spanish can collaborate because finally all the translations will be reviewed. There are no small help, up to a single word counts. We need create a huge community of collaborators. So, we will be happy if you want to promote this initiative among your contacts or within your professional institutions.

Thank you for helps us making IFCC eAcademy knowledge accessible to more professionals.

Contact Silvia Colli Lanzi – IFCC Office for more information

  • Via Carlo Farini, 81 – 20159 Milano – ITALY
  • Tel: +39 0266809912- Fax: +39 0260781846
  • e-mail: ifcc@ifcc.org
  • Web Site: www.ifcc.org

News IFCC – July Issue

0

News from the World of the International Federation of Clinical Chemistry and Laboratory Medicine.

Click here to download the July Issue

Visit www.ifcc.org for more information.

Edited by Tahir Pillay MBChB, PhD, FRCPath(Lon), FCPath(SA)

IFCC members may send news to:

  • Tahir Pillay MBChB, PhD, Head, Dept of Chemical Pathology, Faculty of Health Sciences, University of Pretoria, Private Bag Bag x323, Arcadia, 0007, South Africa
  • el: (27) 12 319-2116; Fax: (27) 328 6000; Email: enews@ifcc.org

 

 

Your Personality Is Controlled By Your Immune System, According To New Study

0

As animals evolved to become increasingly social, their chances of coming into contact with pathogens and catching infections from their companions increased, leading to a greater need for a strong immune system.

Though this link may seem like a logical one, researchers from the University of Virginia have shown for the first time that the immune system of mice directly controls the parts of the brain that are responsible for social behavior, indicating that the evolution of sociability may have occurred as a result of this immunity.

Writing in the journal Nature, the researchers explain how mice that were bred to lack a particular pathogen-fighting immune molecule called interferon gamma (IFN-γ) displayed social deficits and autism-like behavior when interacting with other mice. To try and figure out what was causing this they used functional magnetic resonance imaging (fMRI) to observe the animals’ brain activity.

In doing so, they discovered that certain brain regions in the prefrontal cortex (PFC) that are known to control social behavior had become hyperactive, much like they are in humans with autism.

Following this, the study authors injected the mice with IFN-γ, noting that this instantly caused them to behave like healthy mice, with no social abnormalities. When monitoring the neural activity of these rodents, the team found that the introduction of IFN-γ led to an increase in levels of a neurotransmitter called GABA, which inhibits neurons in the PFC, alleviating their hyperactivity.

Commenting on this discovery, study co-author Jonathan Kipnis explained in a statement that “the brain and the adaptive immune system were thought to be isolated from each other, and any immune activity in the brain was perceived as a sign of a pathology. And now, not only are we showing that they are closely interacting, but some of our behavior traits might have evolved because of our immune response to pathogens.”

To confirm the evolutionary link between immunity and social behavior traits, the researchers analyzed the genomes of a range of rodent species, as well as zebrafish and fruit flies that had been used in previous lab experiments. Amazingly, they discovered that animals that had been housed in social enclosures had an upregulated IFN-γ gene, while animals kept in solitary confinement displayed a downregulation of this gene.

This suggests that these species are all genetically programmed to produce IFN-γ when they interact with others, regardless of whether or not they have been infected with a pathogen. As such, it seems likely that IFN-γ is highly involved with the activation of social behaviors, while simultaneously protecting against any infections that may result from these interactions.

Based on this finding, the study authors speculate that “immunity may also contribute to modulating neuronal circuits that are responsible for our everyday behaviors and personality.” Furthermore, they suggest that many social and personality deficits in humans may, in fact, be caused by faulty immune systems, and hope that this discovery one day leads to new treatments for conditions such as autism and other similar disorders.

Source: IFL Science

IFCC’s Forthcoming Congresses – July Issue

0

Calendar of IFCC Congresses/Conferences and Regional Federation’s Congresses

Nov 26 – 29, 2016 14th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine Congress Taipei, TW
Jun 11 – 15, 2017 IFCC-EFLM EuroMedLab 2017 Athens, GR
Sep 17 – 22, 2017 XXIII COLABLIOCLI Congress 2017 and XI Uruguayan Congress of Clinical Biochemistry Punta del Este, UY
Oct 22 – 25, 2017 XXIII IFCC WorldLab 2017 Durban, ZA
May 18 – 23, 2019 IFCC-EFLM EuroMedLab 2019 Barcelona, ES
May 24 – 28, 2020 XXIV IFCC WorldLab 2020 Seoul Seoul, KR
Oct 20 – 22, 2017   XIV International Congress of Pediatric Laboratory Medicine Durban, ZA

 

Calendar of events with IFCC auspices

May 09 -Dec 09, 2016 Course Quality Management and Good Laboratory Practice, Third Edition, 2015 PAHO/WHO online course
Jun 04 – July17, 2016 High Speciality QC Training Mexico City, MX
Aug 11 – 13, 2016 9th Palestinian Conference of Laboratory Medicine Ramallah, Palestine
Sep 03 – 08, 2016 41st FEBS Congress/FEBS 2016 Kusadasi/Ephesus,TR
Sep 13 – 15, 2016 AACB AIMS 2016 Combined Scientific Meeting Brisbane, AU
Sep 16, 2016 AACB Chromatography Mass Spectometry Satellite Meeting Brisbane, AU
Sep 21 – 24, 2016 4th Joint EFLM-UEMS Congress “Laboratory Medicine at the Clinical Interface” Warsaw, PL
Sep 21 – 24, 2016 The Benefits and Challenges of Point-of-Care Testing across the Clinical Spectrum. 26th International CPOCT Symposium Copenhagen, DK
Sep 28 – 30, 2016 2nd German Congress on Laboratory Medicine DKLM 2016 and 13th Annual Congress of the German Society for Clinical Chemistry and Laboratory Medicine e.V. Mannheim, DE
Sep 29, 2016 SBPC/ML&IFCC Joint Symposium Rio de Janeiro, BR
Sep 30 – 01, 2016 5th Slovenian Congress of Clinical Chemistry and Laboratory Medicine Portoroz, SI
Oct 04 – 08, 2016 First Scientific and Professional Congress of Biochemistry 2016 Cordoba, AR
Oct 05 – 07, 2016 24th Balkan Clinical Laboratory Federation Meeting Tirana, AL
Oct 12 – 14, 2016 2016 Conference of the Association of Clinical Chemists of Nigeria Ikeja, Lagos, NG
Oct 19 – 21, 2016 X National Congress of Clinical Laboratory Zaragoza, ES
Oct 20 – 22, 2016 Joint Meeting of the “3rd Congress on Controversies in Thrombosis & Hemostasis” and the “8th Russian Conference on Clinical Hemostasiology and Hermorheology” Moscow, RU
Oct 26 – 28, 2016 LMCE 2016 & KSLM 57th Annual Meeting Seoul, KR
Oct 27, 2016 International Conference on Laboratory Medicine “Towards performance specifications for the extra-analytical phases of laboratory testing” Padova, IT
Nov 09 – 11, 2016 EFLM Course “Developing medical tests that improve patient outcomes” Leiden, NL
Nov 17 – 18, 2016 10th International Scientific Meeting of the Centre of Metrological Traceability in Laboratory Medicine (CIRME) “Ten years after” Milan, IT
Dec 02 – 03, 2016 Journée de Biologie Praticienne 50 Paris, FR
Feb 09 – 10, 2017 International Congress on Quality in Laboratory Medicine Helsinki, FI

Free Webinar: The Evolution of PTH and Vitamin D Testing

0

This presentation will describe the role of vitamin D and PTH on calcium metabolism and bone health and will also review the metabolism and clinical utility of PTH, 1,25 dihydroxyvitamin D and 25 OH Vitamin D.   The discussion will address how the various laboratory assays are used to diagnose and monitor conditions with abnormal calcium levels.

Learning Objectives

  • Understand the clinical background of PTH, 1,25 Dihydroxyvitamin D and 25 OH Vitamin D
  • Learn the challenges of testing of PTH and Vitamin D
  • Describe the actions and programs for Standardization of Vitamin D and PTH assays.

Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He joined the Department of Laboratory Medicine of the St-Luc University Hospital in 2008. He is now associated laboratory director and leading Endocrine Biology. He is also member of the research unit on Endocrinolgy Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is a member of the committee on distance learning of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), of the IFCC task force for young scientists (Chair between 2010 and 2012 and now consultant), a member of the division of Endocrinology of the American Association of Clinical Chemistry. Pr. D. Gruson is also a Fellow of the European Society of Cardiology.

Go to webinar

Agenda

       

Radio El Microscopio

Ze Xiong

Últimas notas publicadas